CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $321,000 | -69.9% | 38,660 | -72.9% | 0.00% | -100.0% |
| Q3 2019 | $1,065,000 | -47.4% | 142,651 | -21.0% | 0.00% | -50.0% |
| Q2 2019 | $2,026,000 | -43.5% | 180,653 | -45.8% | 0.00% | -50.0% |
| Q1 2019 | $3,584,000 | -21.1% | 333,400 | +10.7% | 0.00% | -20.0% |
| Q4 2018 | $4,542,000 | -45.0% | 301,126 | -32.5% | 0.01% | -28.6% |
| Q3 2018 | $8,255,000 | +2.2% | 446,223 | +26.2% | 0.01% | -12.5% |
| Q2 2018 | $8,081,000 | +383.6% | 353,530 | +501.9% | 0.01% | +300.0% |
| Q1 2018 | $1,671,000 | +44.7% | 58,739 | +7.4% | 0.00% | +100.0% |
| Q4 2017 | $1,155,000 | +16.1% | 54,703 | -0.2% | 0.00% | 0.0% |
| Q3 2017 | $995,000 | – | 54,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |